Gynecological malignant tumors include endometrial cancer, cervical cancer, ovarian cancer, vulvar cancer, fallopian tube cancer, etc. According to statistics, 131,500 new gynecological malignant tumors occur in China every year, which seriously threaten women’s health and survival quality. At present, the main means of treating gynecological malignant tumors are surgery, radiotherapy and chemotherapy. Surgery requires removal of tumor lesions and internal genital organs (uterus, fallopian tubes and ovaries), while radiotherapy and chemotherapy have destructive effects and damage to ovaries, both of which can lead to permanent ovarian function damage. Due to the special significance of uterus and ovaries for women, and the fact that the incidence of gynecologic malignancies tends to be younger in recent years, postoperative patients with gynecologic malignancies have more mental stress and burden than patients with other malignancies. After undergoing surgery and radiotherapy, these patients face the common problems of cancer patients and their special problems during their recovery period. Female patients have lost their reproductive organs and their female hormone levels are even lower. For women in their reproductive years, menopausal symptoms and signs accelerate, bringing about poor physical condition, decreased immune function, osteoporosis and cardiovascular diseases, and can also trigger psychoneurological symptoms of different degrees. The incidence of psychological crisis in patients with gynecologic malignancies is reported to be 20%-50%, which has a serious impact on patients’ physical function and quality of life. Ovarian deficiency syndrome refers to the removal of bilateral ovaries before amenorrhea, low estrogen level in blood, and manifests vasomotor neurological symptoms mainly fever, sweating, facial flushing, other systemic symptoms such as osteoporosis, genitourinary tract atrophy and cardiovascular disease. In 1947, WHO proposed that “health is not only the absence of disease and infirmity, but also a state of physical, mental and social well-being”. With the progress of health concept, Engel, an American medical scientist, proposed the “biopsychosocial model of medicine” in 1977. The focus of clinical medicine also changed from treating the “human disease” to treating the “sick person”, and Health related Quality of Life (HRQOL), which is often related to disease and treatment. Health-related Quality of Life (HRQOL) is often related to disease and treatment. The purpose of malignant tumor treatment is not only to prolong life through various treatments but also to improve the quality of life of patients. There are few studies on the quality of survival of patients with gynecologic malignancies in China, and there are very few quantitative studies. The concept of survival quality has penetrated into all aspects of gynecologic malignancy treatment. Without affecting the efficacy of treatment, more consideration should be given to survival quality in order to take active medical interventions to improve the survival quality of patients. Currently, the treatment of ovarian function decline in Western medicine is mainly based on hormone replacement therapy (HRT). For survivors of gynecologic malignancies, after completing surgery, chemotherapy, radiotherapy and other treatments, they are faced with the problem of how to prolong survival and improve quality of life. However, since hormone therapy is a double-edged sword for these tumor patients, on the one hand, it can relieve the organic discomfort of these tumor patients caused by gonadectomy and treatment; on the other hand, the application of hormone may lead to tumor recurrence or disease progression. In this population of women, there are no exact indications, treatment protocols and follow-up observation processes for the selection and use of hormone therapy. In recent years, many foreign reports have shown that the use of complementary and alternative medicine (CAM) to control menopausal symptoms in gynecologic malignancies has not increased the recurrence of malignant tumors.CAM is a general term for a variety of medications and health care measures, different from the usual medications, including herbs, vitamins, acupuncture, etc. acupuncture, etc. Chinese medicine has an irreplaceable role in the prevention and treatment of ovarian function decline. It is guided by TCM theory, highlighting the holistic concept, taking into account the surface and the root cause of the disease, and playing the advantage of multi-target regulation, which is in line with the trend and requirements of medical development.